LOXL3 and cancer: However, recent studies have revealed that LOXL3 is frequently overexpressed in multiple types of malignant tumors, and its expression level is closely correlated with advanced tumor stage, lymph node metastasis, and poor patient prognosis (Laurentino et al., 2019).